Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Retirees Are Quickly Moving Into These Dividend Funds
09:35am, Thursday, 26'th Feb 2026
Shifting from higher-risk assets to consistent income sources is a natural progression for retirees.
5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills
07:48am, Thursday, 26'th Feb 2026
Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge d
U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer
02:29pm, Tuesday, 24'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination with cetuximab
This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income
09:30am, Tuesday, 24'th Feb 2026
Pfizer is dealing with headwinds right now, but they aren't unusual headwinds in the pharmaceutical sector. The company is taking aggressive actions to get back on track and recently stated it plans t
Pfizer Adds Sciwind As China Partner For New Weight Loss Drug
07:45am, Tuesday, 24'th Feb 2026
In the latest China pharmaceutical industry collaboration pact with a global drug leader, Hangzhou Sciwind Biosciences said today it had reached an agreement with Pfizer China to team up on the commer
This news release constitutes a “designated news release” for the purpose of the Company's prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated September 17,
Pfizer Inc. $PFE Shares Purchased by Dakota Wealth Management
04:49am, Tuesday, 24'th Feb 2026
Dakota Wealth Management grew its stake in shares of Pfizer Inc. (NYSE: PFE) by 33.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 348,386 shares of the bioph
Pfizer in diabetes drug deal with Sciwind Biosciences
10:26pm, Monday, 23'rd Feb 2026
Pfizer has entered an agreement to license Sciwind Biosciences' type 2 diabetes treatment ecnoglutide, with potential payments of up to $495 million if milestones are met, the Chinese drugmaker said o
Novo Nordisk Faces Setback as CagriSema Falls Short in Obesity Trial
02:14pm, Monday, 23'rd Feb 2026
Novo Nordisk (NVO) is experiencing a significant drop in stock value after its obesity drug candidate, CagriSema, failed to meet the primary endpoint in the RED
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 23'rd Feb 2026
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Monday, 23'rd Feb 2026
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD C
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
08:00am, Monday, 23'rd Feb 2026
Installation of second Physical AI platform positions Telescope Innovations to successfully address the rapidly expanding SDL market Vancouver, British Columbia--(Newsfile Corp. - February 23, 2026) -
My 5 Favorite Dividend Stocks to Buy Right Now
01:46pm, Sunday, 22'nd Feb 2026
It may be the right time for investors to start playing a little less offense and a little more defense. The best defensive names, however, are shares of businesses that continue to generate cash flow
Massive News: Pfizer's 6% Dividend Could Be Safer Than You Think
11:00am, Saturday, 21'st Feb 2026
Pfizer (PFE 0.73%) offers a rare mix of scale, stability, and a 6% dividend yield that few large caps can match. With steady cash flow, modest valuation, and analyst upside, this defensive giant may b
Pfizer: A Risky 6.3% Yield For Income-Oriented Investors
11:47pm, Friday, 20'th Feb 2026
Pfizer offers a 6.3% yield, but its high dividend reflects weak growth prospects and looming patent cliffs. PFE's dividend is currently covered by cash flow, but payout ratios are stretched, and susta
